Ascentage Pharma Group International AAPG
NASDAQ AAPG
$16.34 +0.43 (+2.79%)
As of: Oct 21, 2026 · 2:02 PM EDT

Ascentage Pharma Group International (AAPG) Non-Current Assets (2023 - 2026)

Updated

Ascentage Pharma Group International's Non-Current Assets was $139.64 million in Q2 2026, down 12.1% from $158.78 million a year earlier.

Analysis

Ascentage Pharma Group International (AAPG) Non-Current Assets (2023 - 2026) Analysis & Trends

At the end of FY2025, Non-Current Assets at Ascentage Pharma Group International came in at $145.77 million, down 7.0% from FY2024.

  • In earlier years, Non-Current Assets was $156.68 million in FY2024 (-4.2%) and $163.61 million in FY2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Assets (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 77.61 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 141.29 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn 101.45 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn 125.00 Mn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 94.68 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn 87.87 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn 60.68 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn 35.42 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn 159.77 Bn
10 Ascentage Pharma Group International 1.45 Bn 417.61 Mn - 139.64 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 139.64 Mn
Dec 31, 2025 145.77 Mn
Jun 30, 2025 158.78 Mn
Dec 31, 2024 156.68 Mn
Dec 31, 2023 162.69 Mn
API Access

Ascentage Pharma Group International Non-Current Assets API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-assets&ticker=AAPG&period=max&api_key=YOUR_API_KEY